EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Developing New Strategies to Construct Pseudo-natural Macrocycles for Undruggable Targets

Han Wang, Tongyu Bi, Weibo Yang iD

Accounts of Chemical Research · 07.10.2025 · 58 (19) · 3096-3110

DOI: 10.1021/acs.accounts.5c00524 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Accounts of Chemical Research, online erschienen am 15.09.2025. Verfasst von Han Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Hauptthemen laut MEDLINE: Macrocyclic Compounds, Biological Products. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Up to 85% of human-disease-related target proteins are classified as undruggable. These targets play critical roles in disease pathogenesis and progression yet lack effective agents for therapeutic intervention. In recent years, strategies such as proteolysis-targeting chimeras (PROTACs) and molecular glues have emerged to modulate these undruggable targets, demonstrating considerable promise. Notably, macrocyclic compounds used for molecular glues have exhibited exceptional performance. They comprise ring structures typically formed by 12 or more atoms, representing a unique class of three-dimensional molecular architectures that balance conformational flexibility with structural rigidity. Studies indicate that macrocyclization strategies enhance target selectivity, improve binding affinity, and optimize drug-like characteristics of therapeutic candidates. Despite these advances, current macrocyclic drugs predominantly derive from natural products (NPs). Naturally occurring macrocycles often possess structural complexity, are isolated in low yields, and present significant synthetic challenges, thereby limiting their availability for clinical applications. Consequently, the development of innovative methodologies to construct pseudo-natural macrocycles capable of modulating undruggable targets holds substantial scientific and therapeutic importance─yet remains a formidable challenge.Over the past five years, our group has established a modular biomimetic assembly strategy enabling the rapid generation of diverse pseudo-natural macrocycles exhibiting broad bioactivities. Our macrocycle design principle rests on three key tenets: (I) deconstructing natural product biosynthetic logic into programmable building blocks; (II) developing novel reactions to mimic natural bioactive building blocks; and (III) strategically replacing intricate chiral motifs with readily available amino acid derivatives. This paradigm has facilitated the rapid generation of pseudo-natural macrocycles with significant unexplored biological potential. In this Account, we highlight recent progress made in our group toward development of a modular biomimetic strategy and novel macrocyclization reactions to construct a pseudo-natural macrocycles library for modulating undruggable targets. Specifically, we categorize our work into four parts, including construction of a pseudo-natural macrocycles library, macrocyclic oxime modulating Hemagglutinin (HA) for anti-influenza A H1N1, spiro-fused macrocycles targeting silent information regulator (SIRT3) for treating Parkinson's disease, and macrocycles targeting protein-protein interaction (PPI) for overcoming multidrug resistance (MDR). We highlight that structurally diverse, multifunctional bioactive pseudo-natural macrocycles can be produced concisely and sustainably. We hope that this Account delineated herein will broaden the application of this strategy and inspire the design of a variety of pseudo-natural macrocycles for modulating undruggable targets. We believe that continued efforts based on organic synthesis methodology-driven medicinal chemistry will provide practical solutions to critical challenges in drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrocyclic CompoundsBiological ProductsHumans

Substanzen

Macrocyclic CompoundsBiological Products

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.

ORCID-Profile: Weibo Yang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, H., Bi, T., & Yang, W. (2025). Developing New Strategies to Construct Pseudo-natural Macrocycles for Undruggable Targets. Accounts of Chemical Research, 58(19), 3096-3110. https://doi.org/10.1021/acs.accounts.5c00524

Vancouver

Wang H, Bi T, Yang W. Developing New Strategies to Construct Pseudo-natural Macrocycles for Undruggable Targets. Accounts of Chemical Research. 2025;58(19):3096-3110. doi:10.1021/acs.accounts.5c00524

BibTeX
@article{Wang2025,
  author = {Wang, Han and Bi, Tongyu and Yang, Weibo},
  title = {Developing New Strategies to Construct Pseudo-natural Macrocycles for Undruggable Targets},
  journal = {Accounts of Chemical Research},
  year = {2025},
  volume = {58},
  number = {19},
  pages = {3096--3110},
  doi = {10.1021/acs.accounts.5c00524}
}
Kostenlos starten →